Proteins


  •  
  •  
  •  
  •  

  •  
  •  
  •  

  •  
  •  
  •  
  •  
  •  
  •  
  •  

Proteins

MMP2 - hemopexin like domain

Human, recombinant
Residues 467-660, UniProtKB accession P08253
MW = 22.4 kDa
EC # 3.4.24.24
CAT # G04MP02H

MMP20 - catalytic domain

Human, recombinant
Residues 113-271, UniProtKB accession O60882
MW = 17.5 kDa
EC # 3.4.24.-
CAT # G04MP20C

MMP3 - catalytic domain

Human, recombinant
Residues 100-272, UniProtKB accession P08254
MW = 19.5 kDa
EC # 3.4.24.17
CAT # G04MP03C

MMP3 - catalytic domain, inactive mutant

Human, recombinant
Residues 100-272, UniProtKB accession P08254
MW = 19.5 kDa
EC # 3.4.24.17
CAT # G04MP03Ci

MMP3 - catalytic domain, mutant with improved stability

Human, recombinant.
Residues 100-272, UniProtKB accession P08254
MW = 19.5 kDa.
EC # 3.4.24.17
CAT # G04MP03Cm

MMP7 - catalytic domain

Human, recombinant
Residues 95-267, UniProtKB accession P09237
MW = 19.3 kDa
EC # 3.4.24.23
CAT # G04MP07C

MMP8 - catalytic domain

Human, recombinant
Residues 105-262, UniProtKB accession P22894
MW = 17.6 kDa
EC # 3.4.24.34
CAT # G04MP08C

MMP9 - catalytic domain

Human, recombinant
Residues 112-445, UniProtKB accession P14780
MW = 37.7 kDa
EC # 3.4.24.35
CAT # G04MP09C

NSP1

from SARS-CoV-2, recombinant
alternative name: leader protein
Residues 1-180, NCBI reference sequence YP_009725297.1
MW = 19.8 kDa
CAT # G19NP011

NSP10

from SARS-CoV-2, recombinant
alternative name: growth-factor-like protein, GFL
Residues 1-139, NCBI reference sequence YP_009725306.1
MW = 14.8 kDa
CAT # G19NP101

NSP14

from SARS-CoV-2, recombinant
alternative name: 3'-to-5' exonuclease
Residues 1-527, NCBI reference sequence YP_009725309.1
MW = 59.8 kDa
CAT # G19NP141

NSP15

from SARS-CoV-2, recombinant
alternative name: endoRNAse
Residues 1-346, NCBI reference sequence YP_009725310.1
MW = 38.8 kDa
CAT # G19NP151

NSP16

from SARS-CoV-2, recombinant
alternative name: 2'-O-ribose methyltransferase
Residues 1-298, NCBI reference sequence YP_009725311.1
MW = 33.3 kDa
CAT # G19NP161

NSP3, ADP ribose phosphatase domain

from SARS-CoV-2, recombinant
alternative name: ADP ribose phosphatase, nsp3 macro x domain
Residues 206-426, NCBI reference sequence YP_009725299.1
MW = 25.4 kDa
CAT # G19NP031

NSP3, papain-like proteinase domain

from SARS-CoV-2, recombinant
alternative name: papain-like proteinase, nsp3d, Plpro
Residues 746-1060, NCBI reference sequence YP_009725299.1
MW = 36.8 kDa
CAT # G19NP03P1

NSP4, C-terminal cytoplasmic domain

from SARS-CoV-2, recombinant
alternative name: C-terminal cytoplasmic domain of nsp4
Residues 406-500, NCBI reference sequence YP_009742611.1
MW = 10.7 kDa
CAT # G19NP041

NSP5

from SARS-CoV-2, recombinant
alternative name: main protease, 3CLp, 3CL-PRO, 3C-like proteinase
Residues 1-306, NCBI reference sequence YP_009725301.1
MW = 34.2 kDa
CAT # G19NP051

NSP7

from SARS-CoV-2, recombinant
Residues 1-83, NCBI reference sequence YP_009725303.1
MW = 9.2 kDa
CAT # G19NP071

NSP8

from SARS-CoV-2, recombinant
Residues 1-198, NCBI reference sequence YP_009725304.1
MW = 21.9 kDa
CAT # G19NP081

NSP9

from SARS-CoV-2, recombinant
Residues 1-198, NCBI reference sequence YP_009725305.1
MW = 13.6 kDa
CAT # G19NP091

<123>

Proteins

MMP2 - hemopexin like domain

Human, recombinant
Residues 467-660, UniProtKB accession P08253
MW = 22.4 kDa
EC # 3.4.24.24
CAT # G04MP02H

MMP20 - catalytic domain

Human, recombinant
Residues 113-271, UniProtKB accession O60882
MW = 17.5 kDa
EC # 3.4.24.-
CAT # G04MP20C

MMP3 - catalytic domain

Human, recombinant
Residues 100-272, UniProtKB accession P08254
MW = 19.5 kDa
EC # 3.4.24.17
CAT # G04MP03C

MMP3 - catalytic domain, inactive mutant

Human, recombinant
Residues 100-272, UniProtKB accession P08254
MW = 19.5 kDa
EC # 3.4.24.17
CAT # G04MP03Ci

MMP3 - catalytic domain, mutant with improved stability

Human, recombinant.
Residues 100-272, UniProtKB accession P08254
MW = 19.5 kDa.
EC # 3.4.24.17
CAT # G04MP03Cm

MMP7 - catalytic domain

Human, recombinant
Residues 95-267, UniProtKB accession P09237
MW = 19.3 kDa
EC # 3.4.24.23
CAT # G04MP07C

MMP8 - catalytic domain

Human, recombinant
Residues 105-262, UniProtKB accession P22894
MW = 17.6 kDa
EC # 3.4.24.34
CAT # G04MP08C

MMP9 - catalytic domain

Human, recombinant
Residues 112-445, UniProtKB accession P14780
MW = 37.7 kDa
EC # 3.4.24.35
CAT # G04MP09C

NSP1

from SARS-CoV-2, recombinant
alternative name: leader protein
Residues 1-180, NCBI reference sequence YP_009725297.1
MW = 19.8 kDa
CAT # G19NP011

NSP10

from SARS-CoV-2, recombinant
alternative name: growth-factor-like protein, GFL
Residues 1-139, NCBI reference sequence YP_009725306.1
MW = 14.8 kDa
CAT # G19NP101

NSP14

from SARS-CoV-2, recombinant
alternative name: 3'-to-5' exonuclease
Residues 1-527, NCBI reference sequence YP_009725309.1
MW = 59.8 kDa
CAT # G19NP141

NSP15

from SARS-CoV-2, recombinant
alternative name: endoRNAse
Residues 1-346, NCBI reference sequence YP_009725310.1
MW = 38.8 kDa
CAT # G19NP151

NSP16

from SARS-CoV-2, recombinant
alternative name: 2'-O-ribose methyltransferase
Residues 1-298, NCBI reference sequence YP_009725311.1
MW = 33.3 kDa
CAT # G19NP161

NSP3, ADP ribose phosphatase domain

from SARS-CoV-2, recombinant
alternative name: ADP ribose phosphatase, nsp3 macro x domain
Residues 206-426, NCBI reference sequence YP_009725299.1
MW = 25.4 kDa
CAT # G19NP031

NSP3, papain-like proteinase domain

from SARS-CoV-2, recombinant
alternative name: papain-like proteinase, nsp3d, Plpro
Residues 746-1060, NCBI reference sequence YP_009725299.1
MW = 36.8 kDa
CAT # G19NP03P1

NSP4, C-terminal cytoplasmic domain

from SARS-CoV-2, recombinant
alternative name: C-terminal cytoplasmic domain of nsp4
Residues 406-500, NCBI reference sequence YP_009742611.1
MW = 10.7 kDa
CAT # G19NP041

NSP5

from SARS-CoV-2, recombinant
alternative name: main protease, 3CLp, 3CL-PRO, 3C-like proteinase
Residues 1-306, NCBI reference sequence YP_009725301.1
MW = 34.2 kDa
CAT # G19NP051

NSP7

from SARS-CoV-2, recombinant
Residues 1-83, NCBI reference sequence YP_009725303.1
MW = 9.2 kDa
CAT # G19NP071

NSP8

from SARS-CoV-2, recombinant
Residues 1-198, NCBI reference sequence YP_009725304.1
MW = 21.9 kDa
CAT # G19NP081

NSP9

from SARS-CoV-2, recombinant
Residues 1-198, NCBI reference sequence YP_009725305.1
MW = 13.6 kDa
CAT # G19NP091

<123>

Proteins

MMP2 - hemopexin like domain

Human, recombinant
Residues 467-660, UniProtKB accession P08253
MW = 22.4 kDa
EC # 3.4.24.24
CAT # G04MP02H

MMP20 - catalytic domain

Human, recombinant
Residues 113-271, UniProtKB accession O60882
MW = 17.5 kDa
EC # 3.4.24.-
CAT # G04MP20C

MMP3 - catalytic domain

Human, recombinant
Residues 100-272, UniProtKB accession P08254
MW = 19.5 kDa
EC # 3.4.24.17
CAT # G04MP03C

MMP3 - catalytic domain, inactive mutant

Human, recombinant
Residues 100-272, UniProtKB accession P08254
MW = 19.5 kDa
EC # 3.4.24.17
CAT # G04MP03Ci

MMP3 - catalytic domain, mutant with improved stability

Human, recombinant.
Residues 100-272, UniProtKB accession P08254
MW = 19.5 kDa.
EC # 3.4.24.17
CAT # G04MP03Cm

MMP7 - catalytic domain

Human, recombinant
Residues 95-267, UniProtKB accession P09237
MW = 19.3 kDa
EC # 3.4.24.23
CAT # G04MP07C

MMP8 - catalytic domain

Human, recombinant
Residues 105-262, UniProtKB accession P22894
MW = 17.6 kDa
EC # 3.4.24.34
CAT # G04MP08C

MMP9 - catalytic domain

Human, recombinant
Residues 112-445, UniProtKB accession P14780
MW = 37.7 kDa
EC # 3.4.24.35
CAT # G04MP09C

NSP1

from SARS-CoV-2, recombinant
alternative name: leader protein
Residues 1-180, NCBI reference sequence YP_009725297.1
MW = 19.8 kDa
CAT # G19NP011

NSP10

from SARS-CoV-2, recombinant
alternative name: growth-factor-like protein, GFL
Residues 1-139, NCBI reference sequence YP_009725306.1
MW = 14.8 kDa
CAT # G19NP101

NSP14

from SARS-CoV-2, recombinant
alternative name: 3'-to-5' exonuclease
Residues 1-527, NCBI reference sequence YP_009725309.1
MW = 59.8 kDa
CAT # G19NP141

NSP15

from SARS-CoV-2, recombinant
alternative name: endoRNAse
Residues 1-346, NCBI reference sequence YP_009725310.1
MW = 38.8 kDa
CAT # G19NP151

NSP16

from SARS-CoV-2, recombinant
alternative name: 2'-O-ribose methyltransferase
Residues 1-298, NCBI reference sequence YP_009725311.1
MW = 33.3 kDa
CAT # G19NP161

NSP3, ADP ribose phosphatase domain

from SARS-CoV-2, recombinant
alternative name: ADP ribose phosphatase, nsp3 macro x domain
Residues 206-426, NCBI reference sequence YP_009725299.1
MW = 25.4 kDa
CAT # G19NP031

NSP3, papain-like proteinase domain

from SARS-CoV-2, recombinant
alternative name: papain-like proteinase, nsp3d, Plpro
Residues 746-1060, NCBI reference sequence YP_009725299.1
MW = 36.8 kDa
CAT # G19NP03P1

NSP4, C-terminal cytoplasmic domain

from SARS-CoV-2, recombinant
alternative name: C-terminal cytoplasmic domain of nsp4
Residues 406-500, NCBI reference sequence YP_009742611.1
MW = 10.7 kDa
CAT # G19NP041

NSP5

from SARS-CoV-2, recombinant
alternative name: main protease, 3CLp, 3CL-PRO, 3C-like proteinase
Residues 1-306, NCBI reference sequence YP_009725301.1
MW = 34.2 kDa
CAT # G19NP051

NSP7

from SARS-CoV-2, recombinant
Residues 1-83, NCBI reference sequence YP_009725303.1
MW = 9.2 kDa
CAT # G19NP071

NSP8

from SARS-CoV-2, recombinant
Residues 1-198, NCBI reference sequence YP_009725304.1
MW = 21.9 kDa
CAT # G19NP081

NSP9

from SARS-CoV-2, recombinant
Residues 1-198, NCBI reference sequence YP_009725305.1
MW = 13.6 kDa
CAT # G19NP091

<123>
Social media & sharing icons powered by UltimatelySocial

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close